People: Emergent BioSolutions Inc (EBS)

EBS on New York Consolidated

32.85USD
6 Jul 2015
Change (% chg)

$0.49 (+1.51%)
Prev Close
$32.36
Open
$32.04
Day's High
$33.42
Day's Low
$31.75
Volume
157,426
Avg. Vol
249,393
52-wk High
$33.84
52-wk Low
$19.31

Search Stocks

Abdun-Nabi, Daniel 

Mr. Daniel J. Abdun-Nabi is President, Chief Executive Officer, Director of Emergent BioSolutions Inc. since April 2012. From May 2007 to March 2012, Mr. Abdun-Nabi served as our president and chief operating officer. Mr. Abdun-Nabi previously served as our corporate secretary, our senior vice president, corporate affairs and general counsel, and our vice president and general counsel. Prior to joining us, Mr. Abdun-Nabi served as general counsel for IGEN International, Inc., a biotechnology company, and its successor BioVeris Corporation. Prior to joining IGEN, Mr. Abdun-Nabi served as senior vice president, legal affairs, general counsel and secretary of North American Vaccine, Inc. Mr. Abdun-Nabi has served as vice chairman of the board of directors of BioHealth Innovation, a private-public partnership focused on growing the biohealth sector in central Maryland since January 2013 and as a member of the board of directors for the National Association of Manufacturers from March 2012 to March 2014. Mr. Abdun-Nabi received a Master of Law in Taxation from Georgetown University Law Center, a J.D. from the University of San Diego School of Law and a B.A. in political science from the University of Massachusetts, Amherst.

Basic Compensation

Total Annual Compensation, USD 1,180,160
Restricted Stock Awards, USD --
Long-Term Incentive Plans, USD --
All Other, USD 2,967,220
Fiscal Year Total, USD 4,147,390

Options Compensation

  Quantity Market Value
Exercisable 25,900 --
Unexercisable 11,100 --
Exercised 11,576 119,966.00
Name Fiscal Year Total

Fuad El-Hibri

3,591,370

Daniel Abdun-Nabi

4,147,390

Robert Kramer

1,917,990

Adam Havey

1,241,980

Barry Labinger

1,298,660

Ronald Richard

--
As Of  30 Dec 2014
Search Stocks